6 Articles
6 Articles
Indian pharma stocks tumble as Trump signals tariffs on drug imports - The Times of India
Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies like Gland Pharma and Sun Pharma seeing significant declines. Trump's statement highlighted the intention to incentivize pharmaceutical companies to shift production to the US through tariffs, impacting India's substantial generic drug exports to the US.
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources lean Right
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage